- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Patent holdings for IPC class A61K 47/68
Total number of patents in this class: 14681
10-year publication summary
|
570
|
997
|
1224
|
1208
|
1433
|
1492
|
1578
|
1715
|
1871
|
1493
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4800 |
252 |
| SeaGen Inc | 532 |
243 |
| Daiichi Sankyo Company, Limited | 1889 |
237 |
| Genentech, Inc. | 4123 |
205 |
| Hanmi Pharm. Co., Ltd. | 602 |
159 |
| Dyne Therapeutics, Inc. | 262 |
151 |
| MedImmune Limited | 612 |
145 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 399 |
139 |
| ImmunoGen, Inc. | 375 |
126 |
| The Regents of the University of California | 20868 |
124 |
| Bristol-myers Squibb Company | 4757 |
108 |
| Novartis AG | 10174 |
90 |
| Bolt Biotherapeutics, Inc. | 109 |
83 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 720 |
79 |
| Sanofi | 4323 |
74 |
| Zymeworks Inc. | 258 |
71 |
| Genmab A/S | 477 |
71 |
| Hoffmann-La Roche Inc. | 3832 |
70 |
| Pfizer Inc. | 3414 |
70 |
| Yale University | 2565 |
70 |
| Other owners | 12114 |